Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 809714, 7 pages
http://dx.doi.org/10.1155/2015/809714
Clinical Study

A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors

Department of Lymphoma, Sino-US Center for Lymphoma and Leukemia, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tiyuanbei, Huanhuxi Road, Hexi District, Tianjin 300060, China

Received 25 June 2014; Revised 9 October 2014; Accepted 12 October 2014

Academic Editor: Shiwu Zhang

Copyright © 2015 Zhengzi Qian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Zhengzi Qian, Xianhuo Wang, Zheng Song, et al., “A Phase I Trial to Evaluate the Multiple-Dose Safety and Antitumor Activity of Ursolic Acid Liposomes in Subjects with Advanced Solid Tumors,” BioMed Research International, vol. 2015, Article ID 809714, 7 pages, 2015. https://doi.org/10.1155/2015/809714.